TOKAI PHARMACEUTICALS INC's ticker is TKAI and the CUSIP is 88907J107. A total of 50 filers reported holding TOKAI PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $115,000 | -15.4% | 137,129 | -0.9% | 0.00% | – |
| Q4 2016 | $136,000 | +11.5% | 138,329 | +72.1% | 0.00% | – |
| Q3 2016 | $122,000 | -72.2% | 80,357 | +1.0% | 0.00% | – |
| Q2 2016 | $439,000 | -9.9% | 79,596 | -8.3% | 0.00% | – |
| Q1 2016 | $487,000 | -31.0% | 86,767 | +7.2% | 0.00% | – |
| Q4 2015 | $706,000 | -4.5% | 80,913 | +13.2% | 0.00% | – |
| Q3 2015 | $739,000 | -1.6% | 71,497 | +27.0% | 0.00% | – |
| Q2 2015 | $751,000 | +46.7% | 56,303 | +24.2% | 0.00% | – |
| Q1 2015 | $512,000 | +22.8% | 45,349 | +60.1% | 0.00% | – |
| Q4 2014 | $417,000 | – | 28,329 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 511,010 | $2,815,665,000 | 0.61% |
| Perceptive Advisors | 661,041 | $3,642,000 | 0.25% |
| SABBY MANAGEMENT, LLC | 749,205 | $4,128,000 | 0.22% |
| Novo Holdings A/S | 128,993 | $711,000 | 0.08% |
| NJ State Employees Deferred Compensation Plan | 35,000 | $193,000 | 0.04% |
| Alyeska Investment Group, L.P. | 322,297 | $1,776,000 | 0.02% |
| PARADIGM ASSET MANAGEMENT CO LLC | 17,600 | $96,976,000 | 0.02% |
| ROPES WEALTH ADVISORS LLC | 6,000 | $33,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 100,000 | $551,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 3,262 | $17,000 | 0.00% |